What's Raloxifene?

Raloxifene (also known as Evista) is an estrogen receptor modulator. It's used to prevent and treat osteoporosis among postmenopausal females. This medication is used to lower the chance of developing invasive breast carcinoma in women postmenopausal who are high-risk. Raloxifene mimics estrogen's effects in certain areas of the body, while blocking others.

Raloxifene is used in the following ways:

Raloxifene is being studied for its effectiveness in treating osteoporosis postmenopausal women. In a study published in the Journal of Bone and Mineral Research , raloxifene is shown to be able increase bone mineral density and lower the chance of developing vertebral fractures in women suffering from osteoporosis. Although mixed results were found, raloxifene was also studied for hot flashes in postmenopausal women.

Raloxifene was also studied in order to lower the chance of developing invasive breast carcinoma in women postmenopausal who are high-risk. In a study that was published in the New England Journal of Medicine , raloxifene could reduce the incidence of breast cancer in women postmenopausal who are at higher risk.

Raloxifene's Benefits

Raloxifene is known to prevent and treat osteoporosis among postmenopausal females. Research has shown that raloxifene may increase bone mineral density, and decrease the chance of developing vertebral fractures. Additionally, studies have shown that raloxifene can reduce breast cancer risk in women at higher risk after menopause.

Postmenopausal postmenopausal woman may be at lower risk for coronary heart disease if they take raloxifene. The Journal of Clinical Endocrinology and Metabolism published a study that found that raloxifene could reduce the likelihood of developing coronary heart disease among postmenopausal females.

Raloxifene Side Effects

Hot flashes and leg cramps are the most frequent side effects of raloxifene. There are also more severe side effects, such as an increase in stroke risk, deep vein embolism, pulmonary embolism and endometrial carcinoma. Talk to your doctor about potential side effects of raloxifene.

Raloxifene Expert Opinions

Most experts agree that raloxifene can be an effective treatment of postmenopausal bone loss and may help to reduce breast cancer risk in women at higher risk. Experts believe that raloxifene could help lower the chance of developing coronary heart disease among postmenopausal females.

Raloxifene: How do you get started?

Raloxifene can be purchased in tablets and should always be consumed with meals. A daily dose of 60 mg is recommended. Women who are breastfeeding or pregnant should not take raloxifene. Talk to your doctor if you are pregnant or breastfeeding and you should discuss any medications that may interact with raloxifene.

Side effects of raloxifene for women should be discussed with their doctor if there are any hot flashes or leg cramps. Noting that raloxifene can increase your risk of strokes, deep vein thrombosis and pulmonary embolism as well as endometrial carcinoma, is crucial.

Conclusion

Raloxifene, a selective estrogen receptor modator, is used to prevent and treat osteoporosis among postmenopausal females. Raloxifene is prescribed for women at higher risk for invasive breast carcinoma. Research has shown that raloxifene may increase bone mineral density, and decrease the chance of developing vertebral fractures. Postmenopausal woman can have a lower risk of developing coronary heart disease. Raloxifene can be purchased in tablets and should always be consumed with meals. Talk to your doctor about side effects and medications that may interfere with raloxifene.

Finally, raloxifene can be an effective treatment of postmenopausal bone loss and may help lower the chance of developing invasive breast cancer. Additional research suggests that raloxifene could help lower the chance of developing coronary heart disease among postmenopausal females. Talk to your doctor about side effects and medications that may occur when you take raloxifene. Some medications can interact with it.